Phase Ib/II Trial of BEZ235 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer

Clinical trial NCT01495247 · TERMINATED

Trial details

NCT number: NCT01495247
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Inoperable Locally Advanced Breast Cancer Metastatic Breast Cancer (MBC)

Start date: 2012-01-30
Primary completion: 2014-05-19
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.